Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Blacktop politics

Benjamin Franklin once said; “Out of adversity comes opportunity.” The adversity the United States now faces with the coronavirus pandemic is the worst national emergency the country has faced since World War II, more serious, far more deadly, than a...
Richard (Rick) Mills | April 3, 2020 |

Buzz on the Bullboards: A diagnosis on the health of the economy

It has been a bit of a stalemate for North American markets this week as indices nudged one way or another. Earnings report have been rolling in, with some major U.S. banks reporting a slowdown in profits, others saw better-than-expected earnings. Traders are tracking an ...
Jonathon Brown | April 20, 2023 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |

Blockchain Holdings Acquires COVID-19 Quarantine Tracker Already in Use in Hong Kong

The company anticipates adoption of the TRACEsafe system by other countries soon. Blockchain Holdings Ltd. (BCX:CSE) announced that it has entered into a binding letter of intent to acquire "100% of the rights and interests in a self-quarantine monitoring...
Streetwise Reports | March 23, 2020 |

Tronox Shares Trade Up 25% on Preliminary Q1 Financial Results

Shares of Tronox Holdings traded higher after the company released preliminary Q1/20 earnings data and provided an update on its ongoing operations. This morning prior to the opening of U.S. markets, Tronox Ltd. (TROX:NYSE) announced some selected prelimi...
Streetwise Reports | April 20, 2020 |

This Gold & Silver Exploration Company is Drilling THIS Summer in BC’s Golden Triangle

Six months after news of the COVID-19 virus first broke, financial markets around the world are finally starting to shake off the dust. And while a sense of normality may be starting to return, the blows it dealt will likely result in a few resilient bruises. Like the ov...
Oliver Gray | July 3, 2020 |

Buzz on the Bullboards: AI stocks and energy plays getting noticed

Markets have had it rough, starting the month of August lower following one downer of a corporate earnings report after another. Wall Street has struggled since credit assessor Fitch downgraded the United States’ credit rating from gold-standard AAA to...
Jonathon Brown | August 3, 2023 |

Grid Battery Metals ready for forecasted nickel and lithium growth

Grid Battery Metals (TSXV:CELL) is focused on nickel and lithium – two battery metals forecasted to experience rapid growth over the coming decade as the EV and battery sectors expand. The company has its Grid Nickel Group Project in British Columbia and several lithi...
Coreena Robertson | September 12, 2023 |

First Helium creates two premium helium projects in Alberta

The Alberta-focused, cash-flowing, multi-project helium developer First Helium stock (TSXV:HELI) is seeing a demand for its assets. The company has two premier helium projects in Alberta that are high-value, low risk to high-impact exploration opportunities. The company...
Brieanna McCutcheon | July 5, 2023 |
1 2 3 4 5 6 7 8 9 10 ...